Description
Learning Outcomes:
- Recognize key drivers that led to Desmopressin (1-deamino-8-D-arginine vasopressin) (DDAVP) challenge errors.
- Understand the importance of timely lab draws for patients receiving test doses of DDAVP.
- Identify barriers in obtaining appropriate laboratory testing after the administration of the DDAVP test dose.
- Integrate interventions that demonstrated a reduction in errors DDAVP challenge errors.
- Analyze and report data obtained following the incorporation of interventions to reduce DDAVP challenge errors.
Upon successful completion of this course, nurses will earn 1 NCPD. There are no pharmacology hours associated with this activity.
Individual Learning Needs Assessment (ILNA) Coding
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. You may claim 1 NCPD in one of the following ILNA categories: Care Continuum, Psychosocial Dimensions of Care, OR Care of the Pediatric Hem/Onc Patient
Please reach out to the Education Team at education@aphon.org with your name, the email associated with your APHON account, and the above ILNA category you would like to have reflected on your certificate and APHON can update your completion certificate to reflect your choice.
